Latest Cancer: Bladder news
Enfortumab Vedotin Prolongs Survival in Advanced Urothelial Cancer
posted February 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Aspirin Use Tied to Longer Bladder, Breast Cancer Survival
posted January 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Smoking Tied to Worse Bladder Cancer Outcomes After Surgery
posted October 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pancreas Size, Shape Restored With Remission of T2DM
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer Related Articles
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer 
Color Vision Deficiency Associated With Shorter Survival for Patients With Bladder Cancer Monthly Specialist Briefings
Stay Connected
